Feb 07 2025 34 mins 1
Join us in this week as we discuss anal cancer with Dr Rebecca Muirhead.
Based at Oxford University Hospital, Dr Muirhead has played a key role in the adoption of IMRT in anal cancer. She is part of the ACT and PLATO trial group and shares her insights from these trials with us.
We discuss the principles of escalation and de-escalation in the PLATO trial to match the risk of the disease.
Rebecca also very elegantly discusses the pros and cons of re-irradiation in anal cancer to try to regain control of anal caner symptoms in patients where cancer returns.
Enjoy!
